Role Of The LIM-only Protein LMO4 In Lung Development And Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$490,395.00
Summary
Lung cancer is the leading cause of death in cancer patients in Australia. Although treatments have improved in the past 10 years, new therapeutic strategies are eagerly awaited. Deregulation of molecules driving development of normal tissue is often observed in cancer. Our aim is to identify key regulators of lung development and lung repair after injury. We aim to evaluate the role of these molecules in the initiation and progression of lung cancer to identify new targets for therapies.
Regulation Of Lung Stem Cells In Development And Disease
Funder
National Health and Medical Research Council
Funding Amount
$470,143.00
Summary
Breathing air at birth depends on the generation of normal lung structures. Using multiple approaches, we aim to identify factors that control embryonic lung development and adult lung remodeling by stem cells. This will define the molecular events that are critical in normal lung formation that may be altered in lung disorders such as respiratory distress syndrome of prematurity, and will have a significant impact on the future management of lung diseases.
Developmental Functions Of A Novel Zinc-finger Protein
Funder
National Health and Medical Research Council
Funding Amount
$666,812.00
Summary
Diseases of the respiratory track and the immune system represent major public health burdens, from the common cold and lung cancer, to increased risk of infections and auto-immune diseases. We have identified a new gene that is essential for lung development, and required for normal development of antibody-producing immune cells. Here we want to define the mechanism by which this gene functions, in order to better understand how lungs and immune cells develop.